Spire Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.5K | Hold |
308
| – | – | ﹤0.01% | 1817 |
|
|
2025
Q1 | $6.39K | Hold |
308
| – | – | ﹤0.01% | 1990 |
|
|
2024
Q4 | $7.25K | Sell |
308
-1
| -0.3% | -$24 | ﹤0.01% | 1937 |
|
|
2024
Q3 | $7.91K | Sell |
309
-28
| -8% | -$717 | ﹤0.01% | 1704 |
|
|
2024
Q2 | $7.92K | Sell |
337
-104
| -24% | -$2.44K | ﹤0.01% | 1707 |
|
|
2024
Q1 | $12.7K | Buy |
441
+65
| +17% | +$1.87K | ﹤0.01% | 1642 |
|
|
2023
Q4 | $10.8K | Sell |
376
-500
| -57% | -$14.4K | ﹤0.01% | 1735 |
|
|
2023
Q3 | $24.4K | Sell |
876
-362
| -29% | -$10.1K | ﹤0.01% | 1428 |
|
|
2023
Q2 | $42.2K | Sell |
1,238
-96
| -7% | -$3.27K | ﹤0.01% | 1265 |
|
|
2023
Q1 | $40.1K | Buy |
1,334
+471
| +55% | +$14.2K | ﹤0.01% | 1288 |
|
|
2022
Q4 | $24K | Sell |
863
-1,730
| -67% | -$48.1K | ﹤0.01% | 1292 |
|
|
2022
Q3 | $85K | Sell |
2,593
-2,060
| -44% | -$67.5K | 0.01% | 759 |
|
|
2022
Q2 | $147K | Sell |
4,653
-5,432
| -54% | -$172K | 0.01% | 874 |
|
|
2022
Q1 | $463K | Sell |
10,085
-3,049
| -23% | -$140K | 0.01% | 599 |
|
|
2021
Q4 | $804K | Sell |
13,134
-1,153
| -8% | -$70.6K | 0.02% | 544 |
|
|
2021
Q3 | $1.07M | Sell |
14,287
-226
| -2% | -$16.9K | 0.03% | 396 |
|
|
2021
Q2 | $1.34M | Sell |
14,513
-4,919
| -25% | -$455K | 0.04% | 357 |
|
|
2021
Q1 | $1.7M | Buy |
+19,432
| New | +$1.7M | 0.05% | 319 |
|